← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

F

$ Value

$221K

Shares

2,026

Price

$109

Filed

Feb 3

Insider

Name

Garfield Alastair

Title

Chief Scientific Officer

CIK

0002027261

Roles

Officer

Transaction Details

Transaction Date

2026-02-01

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

7,763

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein. | The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date.

Filing Info

Accession No.

0001104659-26-009764

Form Type

4

Issuer CIK

0001649904

Garfield Alastair's History

Date Ticker Type Value
2026-02-11 RYTM A $0
2026-02-11 RYTM A $0
2026-02-01 RYTM M
2026-02-01 RYTM F $221K
2026-02-01 RYTM M $0
2025-07-02 RYTM $85K
2025-07-02 RYTM $388
2025-07-01 RYTM M
2025-07-01 RYTM M $0

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-11
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-11
Smith Hunter C
Chief Financial Officer
$2.2M 2026-02-19
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-11
Cramer Pamela J.
Chief Human Resources Officer
2026-02-11
Shulman Joseph
Chief Technical Officer
2026-02-11
Garfield Alastair
Chief Scientific Officer
2026-02-11